Streetbeat News

Earnings

OPTN

OptiNose reported Q3 earnings per share (EPS) of $(0.08), an improvement from $(0.18) year over year. The company's sales of $19.82M also beat the estimate of $18.68M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:01 pm

CCOI

Cogent Communications reported Q3 2023 earnings per share (EPS) of $(1.20), missing the estimate of $(0.99). The company's revenue was $275.4M, also below the estimated $281.669M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:01 pm

EXAI

Exscientia (NASDAQ:EXAI) reported Q3 2023 GAAP EPS of $(0.31), beating the estimate of $(0.40) by 22.5%. The company also reported quarterly sales of $10.80M, surpassing the estimate of $4.98M by 116.87%. Both figures represent an increase from the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 09, 2023 | 12:01 pm

HBI

Hanesbrands reported Q3 earnings of $0.10 per share, missing the analyst consensus estimate of $0.11 by 9.09%. This is a 65.52% decrease from the same period last year. The company also reported quarterly sales of $1.51 billion, missing the analyst consensus estimate of $1.55 billion by 2.52%. This is a 9.58% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:01 pm

BN

Brookfield (NYSE:BN) reported Q3 earnings of $0.73 per share, missing the analyst consensus estimate of $0.94 by 22.34%. This is a 14.12% decrease from the same period last year. The company also reported quarterly sales of $24.44 billion, missing the analyst consensus estimate of $31.33 billion by 21.99%. This is a 4.37% increase from the same period last year.

Portfolio Pulse from totan@benzinga.com

November 09, 2023 | 12:00 pm

AMLX

Amylyx Pharma (NASDAQ:AMLX) reported Q3 earnings of $0.30 per share, missing the analyst consensus estimate of $0.44 by 31.82%. The company also reported quarterly sales of $102.69 million, missing the analyst consensus estimate of $114.26 million by 10.12%. However, this represents a significant increase from the same period last year.

Portfolio Pulse from bharat@benzinga.com

November 09, 2023 | 12:00 pm

CMAX

CareMax's Q3 Medicare Advantage membership has increased by 171% year-over-year, reaching 107,000 members.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:58 am

DCBO

Docebo reported Q3 adjusted earnings of $0.15 per share, beating the analyst consensus estimate of $0.06 by 150%. The company also reported quarterly sales of $46.50 million, beating the analyst consensus estimate of $46.04 million by 1.00%. This represents a 25.79% increase over sales of $36.97 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:58 am

CMAX

CareMax reported Q3 losses of $(0.92) per share, missing the analyst consensus estimate of $(0.12) by 666.67%. This is a 268% decrease from the same period last year. However, the company reported quarterly sales of $201.84 million, beating the analyst consensus estimate of $194.71 million by 3.66%. This is a 28.02% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:57 am

APD

ET

KDP

XOM

Insider trades were noted in four companies: Energy Transfer LP (ET), Exxon Mobil Corporation (XOM), Keurig Dr Pepper Inc. (KDP), and Air Products and Chemicals, Inc. (APD). ET's Executive Chairman and EVP & Pres. LNG bought shares despite the company's downbeat Q3 earnings. XOM's Director bought shares while UBS maintained a 'Buy' rating but lowered the price target. KDP's COO bought shares following the company's Q3 sales growth. APD's Chairman, Pres. and CEO bought shares after the company reported mixed Q4 results.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 11:52 am